I have interviewed two folks on the very important US vs. Regenerative Sciences legal case: Dr. Chris Centeno and Doug Sipp. More background on the case can be found at the FDA Law Blog. I thank them both for their time and for sharing their unique perspectives. I have specific rules for these interviews and […]
Centeno and Sipp interview on FDA stem cell oversight Read More »
I recently interviewed Kyle Cetrulo of the Perinatal Stem Cell Society. This organization seeks to catalyze big changes in stem cell use and clinical trials in the U.S. In the interview, we touched on many topics including FDA oversight of the cell therapy space. Some of this discussion was in reaction to the new Utah
Concerns after interview with Kyle Cetrulo of Perinatal Stem Cell Society Read More »
There appears to be a big, risky loophole in the relatively new national Right To Try law. Some folks apparently anticipated this problem long ago, but I think most of us weren’t aware of it. Update: More specifically, some law and policy experts were writing about this and other potential loopholes in 2018. I recommend
Right To Try law has a big loophole that’s an opening for bad actors Read More »
There is real hope for treating spinal cord injury with stem cell-based therapies in the future. However, unfortunately regulators in Japan have taken a major misstep in approving a not-ready-for-primetime mesenchymal stem cell (MSC)-based approach to spinal cord injury. Their decision is dangerous and unwise. In a Nature piece (linked to above) by David Cyranoski
Japan’s dangerous gamble approving unproven stem cells for spinal cord injury Read More »
Each year I make a list of predictions for the year to come for the stem cell and regenerative medicine field. Then about a year later I grade myself on how I did as that year winds down. Here’s how I did in 2016. For 2017, late in 2016 I made 20 stem cell predictions. Let’s
Grading my twenty 2017 stem cell predictions Read More »
Why can there be huge clinical trial fees for participants? I am often critical of for-profit stem cell clinics on this blog for numerous reasons. For instance, one thing that concerns me greatly about these clinics is that they charge patients to get experimental “treatments” that have not been proven to be safe or effective. But
Huge clinical trial fees allowed by FDA at times, details often secret Read More »
For years I have been working to educate the community about the predatory stem cell clinics out there. These clinics prey on vulnerable patients and their families. The clinics use hope as a marketing tool. A weapon. As the number of such clinics has mushroomed in the US and elsewhere the risk to both patients
Predatory stem cell clinics are winning: what can we do? Read More »
This post is a tribute to the late Dr. Yoshiki Sasai (笹井芳樹). If you would like your name added to this tribute please let me know. You are also welcome to add your own tributes in the comments. In an era when the emerging field of regenerative medicine is just beginning to take wing, we
Stem Cell Community Tribute to Yoshiki Sasai (笹井芳樹) Read More »
The Knoepfler Lab 2012 Stem Cell Person of the Year is Roman Reed. Congratulations, Roman Reed! Roman made a tremendous difference in 2012 in many ways. One of the most notable was catalyzing the TJ Atchison Spinal Cord Injury Research Act in Alabama, which provides $400,000/year in funding for research. Of course, TJ and many
Stem Cell Person of the Year 2012: Roman Reed Read More »
Stem cell blogs make a big contribution to the stem cell world. Which is the best? It’s a tough choice. This year my pick is stemcellassays.com by Alexey Bersenev as 2012 Stem Cell Blog of the Year. You can also follow Alexey on Twitter here. Congrats to Alexey. Alexey’s blog consistently is outstanding in that it
Stem cell blog of the year 2012: stemcellassays.com by Alexey Bersenev Read More »